Brown Advisory
KURA icon

Brown Advisory’s Kura Oncology KURA Stock Holding History

Brown Advisory’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-627,667
Closed -$6.25M – 975
2020
Q1 		$6.25M Buy
627,667
+2,075
+0.3% +$23.8K 0.02% 340
2019
Q4 		$8.6M Buy
625,592
+2
+0% +$30 0.02% 341
2019
Q3 		$9.49M Buy
625,590
+26,345
+4% +$469K 0.03% 326
2019
Q2 		$11.8M Buy
+599,245
New +$9.95M 0.03% 303

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Brown Advisory's KURA Position: Q2 2020 in Review

Brown Advisory sold out of Kura Oncology (KURA) in Q2 2020, closing a stake of 627,667 shares — an estimated $6.25M sold.

Brown Advisory first reported a position in KURA in Q2 2019 and held it in 4 quarters. The position peaked at $11.8M in Q2 2019. 134 funds tracked by Wall St. Rank hold KURA as of Q2 2020.

  • Brown Advisory reported no remaining Kura Oncology position as of Q2 2020 after selling out during the quarter.
  • Brown Advisory sold 627,667 Kura Oncology shares in Q2 2020, an estimated $6.25M.
  • Brown Advisory first reported a position in Kura Oncology in Q2 2019 and held it in 4 quarters.
  • Brown Advisory's Kura Oncology position peaked at $11.8M in Q2 2019.
  • 134 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2020.

Based on Brown Advisory's 13F filing for Q2 2020, filed 14 Aug 2020.